Rosiglitazone reduces hepatic fat content

Rosiglitazone reduces hepatic fat content

ग्रंथसूची विवरण
मुख्य लेखकों:	Buckingham, R, Toseland, C, Draper, N, Clarke, K
स्वरूप:	Journal article
प्रकाशित:	2000

समान संसाधन

Rosiglitazone prevents ischaemic injury in the obese Zucker rat heart
द्वारा: Sidell, R, और अन्य
प्रकाशित: (2001)

Leukemia and rosiglitazone
द्वारा: Irfan Yavasoglu, और अन्य
प्रकाशित: (2016-03-01)

Sirt1 and Sirt6 mediate beneficial effects of rosiglitazone on hepatic lipid accumulation.
द्वारा: Soo Jin Yang, और अन्य
प्रकाशित: (2014-01-01)

Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.
द्वारा: How, O, और अन्य
प्रकाशित: (2007)

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
द्वारा: Kahn, SE, और अन्य
प्रकाशित: (2006)

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
द्वारा: Lygate, C, और अन्य
प्रकाशित: (2003)

Rosiglitazone-associated fractures in type 2 diabetes
द्वारा: Kahn, SE, और अन्य
प्रकाशित: (2008)

Possible modulation of the antidiabetic effect of rosiglitazone by buspirone
द्वारा: Wafaa R. Mohamed, और अन्य
प्रकाशित: (2012-06-01)

Incidence of diabetes following ramipril or rosiglitazone withdrawal
द्वारा: Holman, R, और अन्य
प्रकाशित: (2011)

Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression
द्वारा: Lingling Yu, और अन्य
प्रकाशित: (2023-04-01)

Guidance on rosiglitazone for type 2 diabetes mellitus.
द्वारा: Matthews, DR
प्रकाशित: (2001)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
द्वारा: Investigators, D
प्रकाशित: (2011)

Isolation, Synthesis and Characterization of Rosiglitazone Maleate Impurities
द्वारा: Singamsetty Radha Krishna, और अन्य
प्रकाशित: (2008-01-01)

Budget impact of rosiglitazone in type 2 diabetes
द्वारा: Orietta Zaniolo, और अन्य
प्रकाशित: (2007-03-01)

Safety and efficacy of rosiglitazone in the elderly diabetic patient
द्वारा: Adie Viljoen, और अन्य
प्रकाशित: (2009-04-01)

The autophagic regulation of rosiglitazone-promoted adipocyte browning
द्वारा: Yue Li, और अन्य
प्रकाशित: (2024-06-01)

Hepatic Angiomyolipoma with Minimal Intratumoral Fat Content
द्वारा: Masataka Banshodani, और अन्य
प्रकाशित: (2009-11-01)

Rosiglitazone , Metformin or both for Treatment of Polycystic Ovary Syndrome
द्वारा: Mohammed A.Taher, और अन्य
प्रकाशित: (2017-03-01)

Rosiglitazone , Metformin or both for Treatment of Polycystic Ovary Syndrome
द्वारा: Mohammed A.Taher, और अन्य
प्रकाशित: (2017-03-01)

Rosiglitazone and myocardial infarction in patients previously prescribed metformin.
द्वारा: Colin R Dormuth, और अन्य
प्रकाशित: (2009-06-01)

RP-HPLC Method for the Simultaneous Estimation of Rosiglitazone and Gliclazide in Tablets
द्वारा: G. Rathinavel, और अन्य
प्रकाशित: (2009-01-01)

Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression
द्वारा: Yong-lin Zhao, और अन्य
प्रकाशित: (2016-01-01)

Effect of Rosiglitazone on Coronary Angiogenesis in Diabetic and Control Rats
द्वारा: Ensieh Salehi, और अन्य
प्रकाशित: (2011-06-01)

Rosiglitazone as an option for patients with acromegaly: a case series
द्वारा: Bahena-García Ana, और अन्य
प्रकाशित: (2011-05-01)

Simpson's paradox visualized: The example of the Rosiglitazone meta-analysis
द्वारा: Schumacher Martin, और अन्य
प्रकाशित: (2008-05-01)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
द्वारा: Demi C. Galindo, और अन्य
प्रकाशित: (2020-07-01)

High Concentrations of Rosiglitazone Reduce mRNA and Protein Levels of LRP1 in HepG2 Cells
द्वारा: Alejandro N. Rondón-Ortiz, और अन्य
प्रकाशित: (2017-11-01)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin.
द्वारा: Colin R. Dormuth, और अन्य
प्रकाशित: (2010-01-01)

Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞
द्वारा: Steven M. Watkins, और अन्य
प्रकाशित: (2002-11-01)

Preventive effects of Salvia officinalis leaf extract on insulin resistance and inflammation in a model of high fat diet-induced obesity in mice that responds to rosiglitazone
द्वारा: Mohamed R. Ben Khedher, और अन्य
प्रकाशित: (2018-01-01)

Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria
द्वारा: Rosauro Varo, और अन्य
प्रकाशित: (2017-05-01)

Co-Administration of Conjugated Linoleic Acid and Rosiglitazone Increases Atherogenic Co-Efficient and Alters Isoprenaline-Induced Vasodilatation in Rats Fed High Fat Diet
द्वारा: Chai, Boon Kheng, और अन्य
प्रकाशित: (2018)

Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
द्वारा: Soo Jin Yang, और अन्य
प्रकाशित: (2011-01-01)

Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
द्वारा: Vladimir Kus, और अन्य
प्रकाशित: (2011-01-01)

Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21?
द्वारा: Martine C. Morrison, और अन्य
प्रकाशित: (2017-06-01)

Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
द्वारा: Lachin, J, और अन्य
प्रकाशित: (2011)

Prenatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Adult Metabolic Phenotype
द्वारा: Hernan Sierra, और अन्य
प्रकाशित: (2012-01-01)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
प्रकाशित: (2010-01-01)

Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
द्वारा: Zinman, B, और अन्य
प्रकाशित: (2010)

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.
द्वारा: Tan, G, और अन्य
प्रकाशित: (2005)